Carbapenem-Resistant Enterobacteriaceae Acquired before Liver Transplantation: Impact on Recipient Outcomes

Transplantation

Volumn 101, Issue 4, 2017, Pages 811-820

  Freire, Maristela Pinheiro ^a   Oshiro, Isabel C V S ^a   Pierrotti, Ligia C ^a   Bonazzi, Patricia R ^a   De Oliveira, Larissa M ^a   Song, Alice T W ^a   Camargo, Carlos H ^b   Van Der Heijden, Inneke M ^a   Rossi, Flavia ^a   Costa, Silvia F ^a   D'Albuquerque, Luiz A C ^a   Abdala, Edson ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE INFECTION; COHORT ANALYSIS; DIALYSIS; ENTEROBACTERIACEAE INFECTION; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; REOPERATION; RISK FACTOR; SURGICAL INFECTION; ADVERSE EFFECTS; ANTIBIOTIC RESISTANCE; CHI SQUARE DISTRIBUTION; ENTEROBACTERIACEAE INFECTIONS; GRAFT RECIPIENT; HEMODIALYSIS; MICROBIOLOGY; MIDDLE AGED; MORTALITY; ODDS RATIO; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; STATISTICAL MODEL; SURGICAL WOUND INFECTION; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

CARBAPENEM DERIVATIVE;

ADOLESCENT; ADULT; AGED; CARBAPENEMS; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SURGICAL WOUND INFECTION; TIME FACTORS; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85007199191     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000001620     Document Type: Article

References (28)

1. Zhong L, Men TY, Li H, et al. Multidrug-resistant gram-negative bacterial infections after liver transplantation-spectrum and risk factors. J Infect. 2012;64:299-310
2. BodroM, Sabé N, Tubau F, et al. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation. 2013;96:843-849
3. Ye QF, Zhao J, Wan QQ, et al. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality. Transpl Infect Dis. 2014;16:767-774
4. van Duin D, van Delden C, AST Infectious Diseases Community of Practice. Multidrug-resistant gram-negative bacteria infections in solid organ transplantation. Am J Transpl. 2013;13(Suppl 4):31-41
5. Freire MP, Abdala E, Moura ML, et al. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients. Infection. 2015;43: 315-323
6. Shi SH, Kong HS, Xu J, et al. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis. 2009;11:405-412
7. Gyung Y, Choi SH, Choo EJ, et al. Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumonia among hospitalized patients. Microb Drug Resist. 2005;11:165-168
8. Kalpoe JS, Sonnenberg E, Factor SH, et al. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 2012;18:468-474
9. Pereira MR, Scully BF, Pouch SM, et al. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 2015;21:1511-1519
10. Lübbert C, Becker-Rux D, Rodloff AC, et al. Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis. Infection. 2014;42:309-316
11. Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785-796
12. CDC/NHSN Surveillance Definitions for Specific Types of Infections. CDC/ NHSN. [Online] January de 2016. http://www.cdc.gov/nhsn/pdfs/ pscmanual/17pscnosinfdef-current.pdf
13. M100-S22: Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Institute, Clinical and Laboratory Standards. 2012;Vol 32 No. 3
14. Gautom RK. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J Clin Microbiol. 1997;35:2977-2980
15. PulseNet/CDC. Pathogens &Protocols. Pulsenet. [Online] April de 2013. http://www.cdc.gov/pulsenet/PDF/ecoli-shigella-salmonella-pfge-protocol-508c.pdf
16. Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of carbapenemresistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014;58:1274-1283
17. Giannella M, Bartoletti M, Morelli MC, et al. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: the importance of pre-and posttransplant colonization. Am J Transplant. 2015;15:1708-1715
18. OliveiraMS, Assis DB, Freire MP, et al. Treatment of KPC-producing Enterobacteriaceae: suboptimal efficacy of polymyxins. Clin Microbiol Infect. 2015;21:179.e1-179.e7
19. Bert F, Larroque B, Dondero F, et al. Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients. Transpl Infect Dis. 2014;16:84-89
20. Kim YJ, Kim SI, Jun YH, et al. Clinical significance of surveillance culture in liver transplant recipients. Transplant Proc. 2014;46:828-831
21. Freire MP, Pierrotti LC, Oshiro IC, et al. Carbapenem resistant Acinetobacter baumannii acquired before liver transplantation: impact on recipient outcomes. Liver Transpl. 2016;22:615-626
22. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580-637
23. Singh N, Gayowski T, Wagener MM. Posttransplantation dialysisassociated infections: morbidity and impact on outcome in liver transplant recipients. Liver Transpl. 2001;7:100-105
24. Bellier C, Bert F, Durand F, et al. Risk factors for Enterobacteriaceae bacteremia after liver transplantation. Transpl Int. 2008;21:755-763
25. García Prado ME, Matia EC, Ciuro FP, et al. Surgical site infection in liver transplant recipients: impact of the type of perioperative prophylaxis. Transplantation. 2008;85:1849-1854
26. Clancy CJ, Chen L, Shields RK, et al. Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients. Am J Transplant. 2013;13:2619-2633
27. Bogan C, Kaye KS, Chopra T, et al. Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysis. Am J Infect Control. 2014;42:612-620
28. Tumbarello M, Trecarichi EM, Rosa FG, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015;70: 2133-2143